GLP0634 will now be developed for Crohn's disease as well.
Novo Nordisk recently announced positive phase III data on its hemophilia B candidate, N9-GP, from the paradigm 2 study.
The acquisition is expected to be accretive to Actavis' 2014 earnings per share by more than 30%.
Simponi can now be used for the treatment of moderately to severely active ulcerative colitis in adults.
Santarus Is a Real Gas!
A response on the progestin-only transdermal contraceptive patch should be out by Dec 27, 2013.
If there are any bears left, I hope they aren't trying to short during this bull rampage.
Santarus, Inc. today announced that additional data from two pivotal clinical studies with UCERIS® extended release tablets will be featured in two poster presentations at the Digestive Disease Week® Meeting being held in Orlando, Fla.